Overview

A Pilot Study of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Parkinson's Disease (MAESTRO)

Status:
Completed

Trial end date:
2018-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to see if the study drug, Mirabegron, is safe and effective in treating symptoms of Overactive Bladder in people with Parkinson's Disease.

Phase:

Phase 4

Details

Lead Sponsor:

Daniel Burdick, MD

Collaborator:

Astellas Pharma US, Inc.

Treatments:

Mirabegron